-
公开(公告)号：US07951790B2
公开(公告)日：2011-05-31
申请号：US11984331
申请日：2007-11-15
Applicant: Ulrike Fuhrmann , Anja Schmidt , Arwed Cleve , Orlin Petrov , Gunnar Garke , Stefan Pruehs , Margarete Brudny-Kloeppel , Antje Rottmann , Rainer Hasselmann , Marcus Schultze-Mosgau , Carsten Moeller
Inventor： Ulrike Fuhrmann , Anja Schmidt , Arwed Cleve , Orlin Petrov , Gunnar Garke , Stefan Pruehs , Margarete Brudny-Kloeppel , Antje Rottmann , Rainer Hasselmann , Marcus Schultze-Mosgau , Carsten Moeller
IPC: A61K31/565 , C07J1/00
Abstract: The present invention relates to progesterone receptor antagonists of general formula I: in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.
-
公开(公告)号：US07902178B2
公开(公告)日：2011-03-08
申请号：US11984331
申请日：2007-11-15
Applicant: Ulrike Fuhrmann , Anja Schmidt , Arwed Cleve , Orlin Petrov , Gunnar Garke , Stefan Pruehs , Margarete Brudny-Kloeppel , Antje Rottmann , Rainer Hasselmann , Marcus Schultze-Mosgau , Carsten Moeller
Inventor： Ulrike Fuhrmann , Anja Schmidt , Arwed Cleve , Orlin Petrov , Gunnar Garke , Stefan Pruehs , Margarete Brudny-Kloeppel , Antje Rottmann , Rainer Hasselmann , Marcus Schultze-Mosgau , Carsten Moeller
IPC: A61K31/565 , C07J1/00
Abstract: The present invention relates to progesterone receptor antagonists of general formula I: in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.
-
公开(公告)号：US20080200440A1
公开(公告)日：2008-08-21
申请号：US11984331
申请日：2007-11-15
Applicant: Ulrike Fuhrmann , Anja Schmidt , Arwed Cleve , Orlin Petrov , Gunnar Garke , Stefan Pruehs , Margarete Brudny-Kloeppel , Antje Rottmann , Rainer Hasselmann , Marcus Schultze-Mosgau , Carsten Moeller
Inventor： Ulrike Fuhrmann , Anja Schmidt , Arwed Cleve , Orlin Petrov , Gunnar Garke , Stefan Pruehs , Margarete Brudny-Kloeppel , Antje Rottmann , Rainer Hasselmann , Marcus Schultze-Mosgau , Carsten Moeller
CPC classification number: C07J1/0081 , C07J21/006 , C07J51/00
Abstract: The present invention relates to progesterone receptor antagonists of general formula I:in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.
Abstract translation: 本发明涉及通式I的孕酮受体拮抗剂：其中R 1可以是氢原子，R 2是羟基或R 1和R 2可以是氧代基。
-
公开(公告)号：US08053426B2
公开(公告)日：2011-11-08
申请号：US11984331
申请日：2007-11-15
Applicant: Ulrike Fuhrmann , Anja Schmidt , Arwed Cleve , Orlin Petrov , Gunnar Garke , Stefan Pruehs , Margarete Brudny-Kloeppel , Antje Rottmann , Rainer Hasselmann , Marcus Schultze-Mosgau , Carsten Moeller
Inventor： Ulrike Fuhrmann , Anja Schmidt , Arwed Cleve , Orlin Petrov , Gunnar Garke , Stefan Pruehs , Margarete Brudny-Kloeppel , Antje Rottmann , Rainer Hasselmann , Marcus Schultze-Mosgau , Carsten Moeller
IPC: A61K31/565 , C07J1/00
CPC classification number: C07J1/0081 , C07J21/006 , C07J51/00
Abstract: The present invention relates to progesterone receptor antagonists of general formula I: in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.
Abstract translation: 本发明涉及通式I的孕酮受体拮抗剂：其中R 1可以是氢原子，R 2是羟基或R 1和R 2可以是氧代基。
-
-
-
Search Results
4
records
(took 0.008 seconds)
